FPRX Insider Trading Activity and SEC Form 4 Filings
FPRX insider trading summary
No open-market insider purchases or sales of Five Prime Therapeutics, Inc. (FPRX) have been reported on SEC Form 4 in the past 12 months.
Latest FPRX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Nov 11, 2020 | Biotechnology Value Fund L P | Insider | Sell | $79.6M (3,941,214 @ $20.19) |
| Nov 11, 2020 | Bvf I Gp LLC | Insider | Sell | $79.6M (3,941,214 @ $20.19) |
| Nov 11, 2020 | Bvf II Gp LLC | Insider | Sell | $79.6M (3,941,214 @ $20.19) |
| Nov 11, 2020 | Bvf Partners L P/Il | Insider | Sell | $79.6M (3,941,214 @ $20.19) |
| Nov 11, 2020 | BVF Partners OS Ltd. | Insider | Sell | $79.6M (3,941,214 @ $20.19) |
| Nov 11, 2020 | Bvf I Gp LLC | Insider | Sell | $59.5M (2,949,477 @ $20.19) |
| Nov 11, 2020 | Biotechnology Value Trading Fund OS LP | Insider | Sell | $10.1M (502,649 @ $20.19) |
| Nov 11, 2020 | Bvf II Gp LLC | Insider | Sell | $10.1M (502,649 @ $20.19) |
| Nov 11, 2020 | Biotechnology Value Trading Fund OS LP | Insider | Sell | $59.5M (2,949,477 @ $20.19) |
| Nov 11, 2020 | Biotechnology Value Trading Fund OS LP | Insider | Sell | $79.6M (3,941,214 @ $20.19) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.